Pirfenidone modulates airway responsiveness, inflammation, and remodeling after repeated challenge
about
Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosisGata5 deficiency causes airway constrictor hyperresponsiveness in mice.Effects of neferine on the pharmacokinetics of amiodarone in rats.New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses.Comprehensive assessment of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosisRequirement for chemokine receptor 5 in the development of allergen-induced airway hyperresponsiveness and inflammationPin1 regulates TGF-beta1 production by activated human and murine eosinophils and contributes to allergic lung fibrosis.Inhibition of neutrophil elastase attenuates airway hyperresponsiveness and inflammation in a mouse model of secondary allergen challenge: neutrophil elastase inhibition attenuates allergic airway responses.Oxidative Modifications of Protein Tyrosyl Residues Are Increased in Plasma of Human Subjects with Interstitial Lung Disease.Pirfenidone inhibits T-cell activation, proliferation, cytokine and chemokine production, and host alloresponses.Effect of a retinoid X receptor partial agonist on airway inflammation and hyperresponsiveness in a murine model of asthma.In the Shadow of Fibrosis: Innate Immune Suppression Mediated by Transforming Growth Factor-β.Inhibitory effects of pirfenidone on dendritic cells and lung allograft rejection.A functional and regulatory map of asthma.Pirfenidone ameliorates concanavalin A-induced hepatitis in mice via modulation of reactive oxygen species/nuclear factor kappa B signalling pathways.The Natural Course of Atopic Dermatitis and the Association with Asthma.
P2860
Q26849378-940F8671-C703-47EE-90EE-CA779F5592FCQ33799596-AD3BFF1A-1268-452B-9926-BD19AE79F6F6Q33950584-DC4C7BCB-4E86-4E52-93C5-20BCAEA02E67Q34432217-7C5FA830-7311-4AD4-B561-19F21D4EB1BBQ34503157-56113E68-7D09-49A7-BF8D-D275657FD2C3Q35684780-A359642E-5FE1-4451-BC33-A9F64237C099Q36330861-C741F042-DCA6-4E4F-B348-A363EADC5CEDQ36604455-0C9FD147-1761-45F5-8C41-13119834CBB1Q36847599-81DEEAD8-4BED-450A-8304-0E78186EAA0DQ37305376-2C31D7DC-60EF-4465-A276-B0AF28AFF46BQ37602684-1CF84CF9-0112-4931-A4B8-CA6BD2D9F551Q38948397-02A6D115-7C24-4A39-87D2-81849ADB6C04Q42246110-A3907ADC-93CF-41B0-A017-A820339BCADFQ43063787-B3FBDB9E-437A-4708-B0A1-BA9E0B996E23Q46478654-4D4E14CF-60E6-475E-9D77-FC4677239D2DQ48003548-E48F8625-6396-4489-A7E9-233CD6A2BDEE
P2860
Pirfenidone modulates airway responsiveness, inflammation, and remodeling after repeated challenge
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Pirfenidone modulates airway r ...... eling after repeated challenge
@ast
Pirfenidone modulates airway r ...... eling after repeated challenge
@en
Pirfenidone modulates airway r ...... eling after repeated challenge
@nl
type
label
Pirfenidone modulates airway r ...... eling after repeated challenge
@ast
Pirfenidone modulates airway r ...... eling after repeated challenge
@en
Pirfenidone modulates airway r ...... eling after repeated challenge
@nl
prefLabel
Pirfenidone modulates airway r ...... eling after repeated challenge
@ast
Pirfenidone modulates airway r ...... eling after repeated challenge
@en
Pirfenidone modulates airway r ...... eling after repeated challenge
@nl
P2093
P2860
P356
P1476
Pirfenidone modulates airway r ...... eling after repeated challenge
@en
P2093
Akio Yoshida
Arihiko Kanehiro
Atsushi Hirano
Chiharu Okada
Hiromi Nakashima
Katsuichiro Ono
Mikio Kataoka
Wataru Ito
Yasushi Tanimoto
P2860
P304
P356
10.1165/RCMB.2005-0452OC
P407
P577
2006-09-01T00:00:00Z